Background-Irreversible electroporation is a promising nonthermal ablation modality able to create deep myocardial lesions. We investigated lesion size after epicardial electroporation catheter ablation with various energy levels after subxiphoid pericardial puncture.
R adiofrequency catheter ablation has become the standard ablation technique for the treatment of cardiac arrhythmias after direct current catheter ablation was abandoned, this was because of the high complication rate attributable to the generation of vapor globe, sparking, explosion, and pressure waves. [1] [2] [3] [4] Since its introduction, epicardial radiofrequency ablation is increasingly being performed for the treatment of ventricular arrhythmias because of ischemic and especially nonischemic cardiomyopathies. 5 Radiofrequency causes heat damage to all tissue near the ablation site. Ablation near coronary arteries can therefore have hazardous adverse effects, such as coagulation of blood inside the vessel and vessel stenosis with subsequent myocardial infarction. [6] [7] [8] In addition, the cooling effect of arterial and endocardial blood flow may limit lesion formation and success of the procedure. 9, 10 
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In recent years, irreversible electroporation has been proposed as a new ablation modality for cardiac arrhythmias. [11] [12] [13] [14] du Pré et al 15 showed that epicardial electroporation ablation over coronary arteries, with a follow-up of 3 weeks, has a low risk of coronary damage and that the use of this technique near or even on large coronary arteries is relatively safe. In addition, lesion formation by electroporation did not seem to be affected by the presence of arterial blood flow. We recently demonstrated that epicardial catheter ablation using 200 J electroporation applications can create extensive and deep myocardial lesions without significant damage to the coronary arteries after a 3-month follow-up period. 16 The purpose of the present study is to investigate the relationship between the magnitude of an epicardial electroporation application and lesion size.
Study Protocol
The study was performed in 6 pigs (weight, 60-75 kg). Amiodarone was started 1 week before the procedure (400 mg QD) to prevent procedure-related arrhythmias. Carbasalate calcium (80 mg QD) and clopidogrel (75 mg QD) were started 3 days before the procedure and continued until euthanasia. The animals were sedated, intubated, and anesthetized according to the standard procedures. Using a subxiphoid pericardial puncture, a custom deflectable octopolar 12-mm circular catheter with 2-mm ring electrodes was introduced in the pericardial space via a 40-cm long 8.5 French deflectable sheath (Agilis EPI Steerable Introducer, St. Jude Medical, St. Paul, MN; Figure 1 ). After left anterior descending coronary artery and circumflex coronary artery angiography, 3 single, QRS-wave triggered, cathodal 50, 100 or 200 J applications were delivered on 3 nonoverlapping left ventricular (LV) locations: the midanterior LV, the anterior-apical LV, and the midlateral LV. In each animal, 50, 100, and 200 J were delivered in random sequence. The energy was generated by a monophasic external defibrillator (Lifepak 9, Physio-Control, Inc, Redmond, WA). A large skin patch (7506, Valleylab Inc, Boulder, CO) on the lower back served as indifferent electrode. 13, 14 A cathodal polarity was chosen because that has the highest threshold for arcing in a blood environment. 18 The impulse waveform was similar to that applied in our earlier studies. 13, 14 Coronary arteries were not specifically targeted, but coronary angiography was repeated after the last application.
After 3-month survival, coronary angiography of the left anterior descending coronary and circumflex coronary arteries was repeated, the thorax was opened by sternotomy, and the animal was euthanized by exsanguination. After the heart was removed, the pericardium was peeled off and the areas with ablation lesions were excised and fixated in formalin.
Histological Evaluation
After fixation, three 4.0-mm wide segments were dissected from each lesion perpendicular to the epicardial surface to facilitate measurement of lesion width and depth. The first segment (A) was taken through the middle of what visibly appeared to be the center of the circular lesion; 2 other segments (B and C) were dissected perpendicular to that first segment, again through the apparent center of the lesion. ( Figure 2 ) After embedding in paraffin, these segments were sectioned and stained with hematoxylin-eosin and with elastic van Gieson. All histological sections were digitally scanned and analyzed using Imagescope (Aperio Technologies). Lesion size was measured in each section.
Measurement of Lesion Size
Two investigators, blinded for the energy settings used, independently measured lesion depth and width: maximal lesion depth was measured in segment A. Lesion width was calculated as the average value of lesion width in segment A and the sum of lesion widths in segments B and C plus 4.0 mm. Values obtained by the 2 blinded investigators were averaged. Large lesions often showed tissue shrinkage, as also seen after myocardial infarction. 19 When sufficient undamaged myocardium was present in the histological section, the estimated original epicardial contour was used to measure lesion depth. 14 With relatively deep lesions, tissue shrinkage apparently also affected the endocardial contour and then also the estimated original endocardial contour was used to measure lesion depth.
Evaluation of the Coronary Arteries
All pre-and postablation angiograms were qualitatively analyzed by 2 experienced investigators. Consensus had to be reached on the degree of luminal narrowing. All histological cross sections were analyzed for the degree of intimal hyperplasia of the coronary arteries.
Statistical Analysis
The relationship between delivered peak current and mean lesion depth and width was calculated by randomized block regression analysis using Tukey's multiple comparison post hoc test. Continuous variables were expressed as mean±SD. Statistical significance was defined as P≤0.05.
Results
Five animals survived the procedure and the 3-month follow-up period without complications. One animal had to be euthanized acutely before electroporation applications had been delivered because of complications caused by failed what visibly appeared to be the center of the circular lesion (gray circle); 2 other lesion segments (B and C) were dissected perpendicular to that first segment, again aside from the apparent center of the lesion. The histological sections were taken from the side of the segment, which went through the center of the lesion. Maximal lesion depth was measured in lesion segment A, lesion width was calculated as the average value of lesion width in lesion segment A and the sum of lesion widths in lesions segments B and C plus 4.0 mm. subxiphoid puncture. The novel ablation catheter had never been deployed in this animal.
Pericardial Ablation
All recorded voltage and current waveforms were smooth, suggesting the absence of arcing. 13 Average peak currents of the 50, 100, and 200 J applications were 11.6±1.4, 19.0±1.5, and 27.1±0.7 A, respectively (Table) .
Macroscopic Findings
Careful inspection of the organs adjacent to the pericardium showed no abnormalities in any animal. No macroscopic signs of bleeding, scarring, or excessive fibrotic tissue proliferation were found
Lesion Size
In 5 animals, 43 cross sections from 15 electroporation lesions were analyzed. In total, we obtained 15 cross sections from five 50-J lesions, 13 cross sections from five 100-J lesions, and 15 cross sections from five 200-J lesions (Figure 3) .
At visual inspection after euthanization, the lesions had a circular, whitish aspect on the epicardial surface with denting in the center of the lesion, because of tissue shrinkage. All but one of the lesions showed continuous lesions, with a sharp demarcation between the ablation lesion and the surrounding tissue. Because of vital myocardium in the center of the lesion, one 50-J lesion did not show 1 continuous lesion, but 2 separate lesions in segment A ( Figure 4 ). For this lesion we averaged lesion depths observed in the 3 histological sections; because of the absence of a continuous lesion we could not calculate a lesion width in this lesion.
Lesion Depth
Mean depth (range) of the 50-, 100-, and the 200-J lesions was 5.0±2.1 (range, 2.8-7.4) mm, 7.0±2.0 (range, 4.4-9.3) mm, and 11.9±1.5 (range, 10.0-13.9) mm, respectively ( Figure 5 ). Mean depth of all lesions combined was 8.0±3.4 mm. In the 100-J, and especially in the 200-J lesions, significant shrinkage caused by scar contracture was obvious. The difference in depth between the respective lesions was statistically highly significant (P<0.001). In more detail, the differences in depth between the 50-versus 200-J lesions and the 100-versus 200-J lesions were statistically significant (P<0.001 and P=0.003, respectively). The difference in depth between the 50-and 100-J lesions was not statistically significant (P=0.18). Transmurality of the lesion was seen in 20% of the 100-J lesions and in 80% of the 200-J lesions. Figure 6 ).
Lesion Width

Coronary Angiography
All preablation coronary angiograms were normal. Postablation coronary angiography demonstrated short-lasting (<30 minutes) luminal narrowing with subsequent normalization in the targeted area, suggestive of coronary spasm. After 3-month survival, there was no significant narrowing of any coronary artery. Visually, all coronary angiograms resembled the preablation coronary angiograms. No significant intimal hyperplasia of coronary arteries was seen in any histological section.
Discussion
Epicardial radiofrequency ablation has a long history. From the first publication by Sosa et al, 20 percutaneous epicardial Ablations were performed with 50, 100, and 200 J. Lesion depth and width were measured in all histological cross sections. Lesion transmurality was determined per lesion. Data are given as the mean±SD. radiofrequency ablation is nowadays being performed in many electrophysiological centers and for a variety of indications, mainly ablation of ventricular tachycardia. 21 However, severe complications, such as damage to the coronary arteries and the phrenic nerve, were described soon after the introduction of epicardial radiofrequency ablation. 22, 23 Since then, many techniques have been introduced with varying success to prevent severe complications, such as coronary angiography, 21 endocardial ablation with an ablation catheter equipped with a retractable needle, 24 endocardial ablation to reduce or obviate epicardial ablation, 25 and injection of air or saline into the pericardium. 26 Recently, Wittkampf et al 14 and du Pré et al 15 have demonstrated that epicardial ablation using electroporation in pigs is feasible, safe, and causes only minimal damage to the coronary arteries. These ablations were performed in an open-chest model, where the epicardium was surgically exposed. This is not the regular, clinical approach when performing epicardial ablation in humans. Therefore, we recently demonstrated that closed-chest epicardial catheter ablation using electroporation is feasible, safe, and able to create deep myocardial lesions. 16 Ablation with 200 J electroporation applications on top of main coronary arteries only caused temporary spasm and a median of 4±10% luminal stenosis.
Electroporation Pulse and Catheter Model
Between 1980 and 1990, direct current catheter ablation was the only energy source available for catheter ablation. At the end of that era, low-energy direct current ablation was developed, but soon thereafter it was replaced by the more elegant radiofrequency ablation technique. In the present and earlier studies, we used a readily available monophasic defibrillator to deliver the electroporation pulse. [13] [14] [15] However, instead of using a single electrode, a circular arrangement of 8 electrically connected electrodes was used in the present study for application of electroporation energy.
In general, a circular electrode catheter has an important advantage over a single ablation electrode for the application of electric current. Although the latter creates an exponential decay in current density with increasing distance from the ablation electrode, a circular arrangement of electrically connected electrodes creates a thorus-shaped electric field near to and around the ablation hoop, at least in a first approximation. The surface area of a thorus relates linearly to the thickness of the thorus. Therefore, current density will initially decrease linearly with increasing distance from the ablation hoop and not exponentially. Penetration depth of an electroporation pulse will therefore be greater with such an ablation hoop than with a single ablation electrode. In addition, a circular multielectrode arrangement will allow for faster electrophysiological mapping than a linear electrode catheter because it can be used to determine not only the timing but also the direction of the activation wavefront. Finally, the 8-ring electrodes of 2-mm length have a total surface area of 115 mm 2 , which definitively allows for a higher arcing threshold than a single electrode; even an 8-mm 7F electrode only has a total surface area of 58 mm 2 and such a large electrode has poor mapping characteristics.
Lesion Size
In this study, we were able to create deep, wide, and continuous lesions. There was a significant relationship between magnitude of the electroporation application and lesion depth and width, with a larger magnitude of the application a larger myocardial lesion could be created. Where a single 50 J application was able to create myocardial lesions ≤7.4-mm deep and 17.7-mm wide, single 200 J applications created myocardial lesions ≤13.9-mm deep and 21.3-mm wide. These 200 J electroporation applications are sufficiently powerful to create transmural ventricular lesions. There were no adverse effects associated with these applications. 27, 28 Mean width of all lesions was 18.2±1.9 mm. The widest 200-J lesion was 21.3 mm; this is ≈2× the width of the diameter of the ablation catheter itself. Although ≤21-mm-wide lesions might be undesirable for the ablation of a focal epicardial source of arrhythmia, lesions of this width might be useful and effective when homogenization of a large area of epicardial scar tissue is required. With future catheter design and further titration of energy settings, it should be possible to find the optimal energy settings for clinical applications.
Effect on Coronary Arteries
The coronary arteries were not specifically targeted in this study, but they were also not purposely avoided. Apart from short-lasting (<30 minutes) coronary spasm, no long-term luminal narrowing was seen. After 3-month follow-up, the luminal diameters of the main coronary arteries were similar to the baseline luminal diameters. These data support the findings of du Pré et al 15 and our previous findings; 16 similar results were found after a follow-up period of 3 weeks and 3 months, respectively.
Clinical Implications
Data from this study and previous studies suggest that epicardial electroporation ablation is a safe and effective ablation modality. 15, 16 It is able to create large and deep myocardial lesions while sparing the coronary arteries; electroporation ablation is the first and only ablation modality capable of doing so. Using this new technology, safe and effective epicardial ablation on or near coronary arteries can become a real possibility for the treatment of ventricular tachycardias, which would otherwise not be treatable with catheter ablation.
Also, deep intramural foci of ventricular arrhythmia will become within reach of catheter ablation using electroporation because a single 200 J electroporation application is able to safely create deep, continuous, and transmural myocardial lesions. This desirable feature is also unique for electroporation ablation.
The clinical introduction of epicardial electroporation ablation could possibly significantly change the way epicardial ablation is being performed.
Limitations
We investigated only 3 energy settings: 50, 100, and 200 J. We have no information on lesion size or adverse effects when using other energy settings.
Significant shrinkage caused by scar contracture of the 100-J and especially the 200-J lesions definitively caused underestimation of lesion size. Also, transmurality of the lesion could have caused underestimation of lesion depth.
Although we did not record any arrhythmia after the ablation nor experienced sudden death in the animals during follow-up, we cannot exclude the occurrence of proarrhythmic effects after electroporation ablation.
We did not investigate the possible negative influence of (the amount of) epicardial fat or preexisting myocardial fibrosis on lesion size.
In this study, the electroporation ablation catheter was placed on the LV epicardium to investigate the effects of certain energy settings on lesion size. Although we might expect a similar outcome, we do not have information about lesion size created by epicardial electroporation ablation in atrial tissue.
Lesion size and form with electroporation ablation will depend on the ultimate catheter/device design and measures to ensure electrode-tissue contact. Given the experimental character of this study, extrapolation of the results of this study to final catheter/device design should be performed with great caution.
Conclusions
Epicardial electroporation ablation after subxiphoid pericardial puncture can create deep, wide, and transmural ventricular myocardial lesions. There is a significant relationship between the amounts of electroporation energy delivered epicardially and lesion size in the absence of major adverse events.
